Editorial Board

Marco Davila, MD, PhD, Roswell Park Comprehensive Cancer Center, Buffalo, NY (Cell therapy, leukemia, lymphoma, myeloma)
Maria Ester Bernardo, MD, PhD, "Vita-Salute San Raffaele" University Medical School, Milan, Italy (Transplantation, gene therapy, cell therapy, inborn errors)
Dan Kaufman, MD, PhD, University of California- San Diego, La Jolla, CA (Stem cells, natural killer cells)
Marie Jose Kersten, MD, PhD, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands (Lymphoma, Waldenström's macroglobulinemia, cell therapy, bispecifics)
Marcela Maus, MD, PhD, Massachusetts General Hospital, Harvard Medical School Cancer Center, Charlestown, MA (Cell therapy, immunotherapy, immunology)
Fabiana Perna, MD, PhD, Moffitt Cancer Center, Tampa, FL (Hematologic malignancies, cell therapy, CAR target discovery)
Claire Roddie, MD, PhD, University College London Cancer Institute, London, UK (Cell therapy)
Axel Schambach, PhD, Hanover Medical School, Hanover, Germany (Transplantation, cell and developmental biology)
Eric Smith, MD, PhD, Dana-Farber Cancer Institute, Boston, MA (Cell therapy)
Marion Subklewe, MD, Gene Center Munich, Munich, Bavaria, Germany (Acute leukemia, lymphoma, immunotherapy, cell therapy, bispecifics)
Evan Weber, PhD, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (Cell therapy/biology, immunotherapy)